In a population carefully screened for major psychiatric conditions, this study found the opposite trend
Initially used to treat type 2 diabetes and, more recently, approved for weight management, medications in this class include liraglutide (Saxenda), semaglutide (Ozempic/Wegovy), and dulaglutide (Trulicity)
Mounjaro, DailyMed (2025) Ozempic, DailyMed (2025) Wegovy, DailyMed (2024) Rybelsus, DailyMed (2024) Zepbound, DailyMed (2025) Metformin, DailyMed (2020) Januvia, DailyMed (2024) Vitamins, minerals, and supplements, American Diabetes Association Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes2022 , American Diabetes Association (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
L Carnitine Market Research Report By Form (L-Carnitine L-Tartrate, Acetyl-L-Carnitine, Propionyl-L-Carnitine, Other Forms), By Application (Dietary Supplements, Food and Beverages, Animal Feed, Pharmaceuticals, Others), By Distribution Channel (Online Retail, Pharmacies, Retail Stores, Direct Sales, Other Channels) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 ID: MRFR/CnM/24481-HCR 111 Pages Last Updated: April 06, 2026 L Carnitine Market Market Size Forecast Period2025 - 2035 CAGR (2025 - 2035)8.11% 2024 Market Size$ 1.6 Billion 2025 Market Size$ 1.74 Billion 2035 Market Size$ 3.78 Billion Key Players Lonza Aceto Corporation Nutraceutical Corporation Sigma-Tau Pharmaceuticals Carlyle Group Jiangsu Wuzhong Pharmaceutical Trends Rising Demand for Natural Ingredients Growth in E-commerce Channels Focus on Personalized Nutrition Opportunities Increasing Health Consciousness Expansion of Sports Nutrition Sector Growing Interest in Preventive Healthcare L Carnitine Market Summary As per Market Research Future analysis, the L Carnitine Market Size was estimated at 1.605 USD Billion in 2024
